Stevanato Group S.p.A. Ordinary Shares (NY:STVN)

19.86 UNCHANGED

Delayed Quote Updated: 7:00 PM EDT, Oct 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Stevanato Group S.p.A. Ordinary Shares

< Previous 1 2 3 4 5 6 Next >

Stevanato Group to Participate in Two Upcoming Investor Conferences

September 08, 2026

From Stevanato Group S.p.A.

Via Business Wire

Stevanato Group Q2 Earnings Call Highlights ↗

August 09, 2026

Stevanato Group (NYSE:STVN) reported second-quarter 2026 revenue growth of 8% as demand for higher-value drug containment and delivery products helped lift profitability, while the company updated its...

Via MarketBeat

Topics Earnings

Stevanato (STVN) Q2 2026 Earnings Call Transcript ↗

August 04, 2026

Revenue grew 8% as high-value solutions surged 16%, driving adjusted EBITDA up 21%.

Via The Motley Fool

Topics Earnings

Earnings Scheduled For November 6, 2025 ↗

November 06, 2025

Via Benzinga

How Is The Market Feeling About Stevanato Group? ↗

August 28, 2025

Via Benzinga

Stevanato Group Q2 2026 Earnings Call: Complete Transcript ↗

August 04, 2026

Stevanato Group (NYSE:STVN) held its second-quarter earnings conference call on Tuesday. Below is the complete transcript from the call. Benzinga APIs provide real-time access to earnings call...

Via Benzinga

Topics Earnings

Stevanato Group Delivers 8% Revenue Growth for the Second Quarter of Fiscal 2026

August 04, 2026

From Stevanato Group S.p.A.

Via Business Wire

Liraglutide Combination Products Incorporating Stevanato Group's Alina® Pen Injector Received Marketing Authorizations in Multiple European Countries

July 30, 2026

From Stevanato Group S.p.A.

Via Business Wire

Stevanato Group to Report Second Quarter 2026 Financial Results on August 4, 2026

July 21, 2026

From Stevanato Group S.p.A

Via Business Wire

2 Dirt Cheap Healthcare Stocks to Buy With $1,000 Right Now ↗

June 09, 2026

Italian healthcare vials and cartridges maker Stevanato Group and U.S. generic and wholesale pharmaceutical company Cencora are two of the best healthcare buys right now.

Via The Motley Fool

Topics Economy

Stevanato Group Introduces Deora™, a Pen Injector for Subcutaneous Delivery in Diabetes and Weight Management

June 08, 2026

From Stevanato Group

Via Business Wire

Stevanato Group Announces Results of Ordinary and Extraordinary Shareholders’ Meeting

June 03, 2026

From Stevanato Group S.p.A.

Via Business Wire

Stevanato (STVN) Q1 2026 Earnings Transcript ↗

May 08, 2026

Stevanato (STVN) Q1 2026 Earnings Transcript

Via The Motley Fool

Topics World Trade

Stevanato Group Delivers 7% Revenue Growth (10% at Constant Currency) for the First Quarter of Fiscal 2026

May 07, 2026

From Stevanato Group S.p.A.

Via Business Wire

Stevanato Group to Participate in Three Upcoming Investor Conferences

May 04, 2026

From Stevanato Group S.p.A.

Via Business Wire

Stevanato Group to Report First Quarter 2026 Financial Results on May 7, 2026

April 23, 2026

From Stevanato Group

Via Business Wire

Stevanato Group to Participate in the KeyBanc Capital Markets Virtual Healthcare Forum

March 12, 2026

From Stevanato Group S.p.A.

Via Business Wire

End of an Era: West Pharmaceutical Shares Slide as Longtime CEO Eric Green Announces Retirement

March 11, 2026

Shares of West Pharmaceutical Services (NYSE: WST) tumbled 5.7% on Tuesday following the announcement that Eric Green, the company’s President, Chief Executive Officer, and Chair of the Board, intends...

Via MarketMinute

Topics Economy Retirement

Stevanato (STVN) Q4 2025 Earnings Call Transcript ↗

March 04, 2026

Stevanato (STVN) Q4 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

Stevanato Group Delivers 7% Revenue Growth (9% at Constant Currency) for Fiscal Year 2025, Including Record Revenue from High-Value Solutions and Expanded Margins

March 04, 2026

From Stevanato Group S.p.A.

Via Business Wire

Stevanato Group to Report Fourth Quarter and Fiscal Year 2025 Financial Results on March 4, 2026

February 19, 2026

From Stevanato Group

Via Business Wire

The Biotech Revolution’s Ultimate ‘Picks and Shovels’ Play: A Deep Dive into West Pharmaceutical Services (WST)

December 23, 2025

As the pharmaceutical industry undergoes its most significant transformation in decades, the spotlight often falls on the blockbuster drugs themselves—the weight-loss miracles and the life-saving...

Via MarketMinute

Topics Economy

Picks and Shovels of the Biotech Revolution: A Deep Dive into West Pharmaceutical Services (WST)

December 23, 2025

Date: December 23, 2025 Introduction In the high-stakes world of biotechnology and pharmaceutical manufacturing, few companies are as indispensable yet as quietly influential as West Pharmaceutical...

Via PredictStreet

Topics Economy Intellectual Property Supply Chain

Stevanato (STVN) Q3 2025 Earnings Call Transcript ↗

November 06, 2025

Stevanato (STVN) Q3 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings World Trade

Stevanato Group SPA (NYSE:STVN) Tops Q3 2025 Earnings and Revenue Estimates ↗

November 06, 2025

Stevanato Group (STVN) beat Q3 2025 earnings and revenue estimates, driven by record high-value solutions and strong demand for its syringes.

Via Chartmill

Stevanato Group Reports Revenue of €303.2 Million for the Third Quarter of 2025

November 06, 2025

From Stevanato Group S.p.A.

Via Business Wire

Stevanato Group to Participate in Upcoming Investor Conferences

October 31, 2025

From Stevanato Group S.p.A.

Via Business Wire

Stevanato Group to Report Third Quarter 2025 Financial Results on November 6, 2025

October 22, 2025

From Stevanato Group

Via Business Wire

Stevanato Group Expands Drug Delivery Systems Capacity to Strengthen Global Integrated Offerings

October 21, 2025

From Stevanato Group

Via Business Wire

Stevanato Group to Participate in Upcoming Investor Conferences

September 02, 2025

From Stevanato Group S.p.A.

Via Business Wire

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.